• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于预测局部晚期分化型甲状腺癌患者癌症特异性生存的动态列线图和风险分层系统:一项基于人群的研究。

A dynamic nomogram and risk stratification system for predicting cancer-specific survival in patients with locally advanced differentiated thyroid cancer: a population-based study.

作者信息

Yuan Jie, Li Zhirong, Tu Likuan, Cao Yijia, Li Qing, Li Fan

机构信息

Department of General Surgery, University-Town Hospital of Chongqing Medical University, Chongqing, China.

Department of Surgery and Anesthesiology, University-Town Hospital of Chongqing Medical University, Chongqing, China.

出版信息

Gland Surg. 2025 Aug 31;14(8):1497-1509. doi: 10.21037/gs-2025-111. Epub 2025 Aug 26.

DOI:10.21037/gs-2025-111
PMID:40948924
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12432967/
Abstract

BACKGROUND

Locally advanced differentiated thyroid cancer (LADTC) refers to a severe stage of differentiated thyroid cancer (DTC) with a relatively poor prognosis. This study aimed to construct a dynamic nomogram and risk stratification system to predict cancer-specific survival (CSS) in patients with LADTC.

METHODS

A total of 4,856 patients diagnosed with LADTC from 2004 to 2020 were included from the Surveillance, Epidemiology, and End Results database. Least absolute shrinkage and selection operator (LASSO) and Cox regression analyses were utilized to identify variables and construct the dynamic nomogram. The performance of the nomogram was assessed using the concordance index (C-index), time-dependent receiver operating characteristic (ROC) curve, area under the curve (AUC), and calibration plot, while decision curve analysis (DCA) was conducted to evaluate clinical benefits. The improvement of the nomogram in comparison to the American Joint Committee on Cancer (AJCC) staging system was evaluated using the C-index, net reclassification index (NRI), and integrated discrimination improvement (IDI). A risk stratification system was established according to the total score of each patient in the nomogram.

RESULTS

Eight variables were identified to construct the nomogram. The C-index, time-dependent ROC curve, AUC, calibration plot, and DCA demonstrated the strong performance and clinical benefits of the nomogram. The C-index, NRI, and IDI indicated that the nomogram outperformed the AJCC staging system in prognostic prediction. The risk stratification system demonstrated the favorable ability to categorize patients with LADTC.

CONCLUSIONS

A dynamic nomogram and risk stratification system were constructed and validated to assist clinicians in evaluating prognostic risk and devising personalized treatment strategies for patients with LADTC.

摘要

背景

局部晚期分化型甲状腺癌(LADTC)是分化型甲状腺癌(DTC)的一个严重阶段,预后相对较差。本研究旨在构建一个动态列线图和风险分层系统,以预测LADTC患者的癌症特异性生存(CSS)。

方法

从监测、流行病学和最终结果数据库中纳入了2004年至2020年期间诊断为LADTC的4856例患者。采用最小绝对收缩和选择算子(LASSO)和Cox回归分析来识别变量并构建动态列线图。使用一致性指数(C指数)、时间依赖性受试者工作特征(ROC)曲线、曲线下面积(AUC)和校准图评估列线图的性能,同时进行决策曲线分析(DCA)以评估临床益处。使用C指数、净重新分类指数(NRI)和综合鉴别改善(IDI)评估列线图相对于美国癌症联合委员会(AJCC)分期系统的改进。根据列线图中每位患者的总分建立风险分层系统。

结果

确定了8个变量来构建列线图。C指数、时间依赖性ROC曲线、AUC、校准图和DCA显示了列线图的强大性能和临床益处。C指数、NRI和IDI表明列线图在预后预测方面优于AJCC分期系统。风险分层系统显示出对LADTC患者进行分类的良好能力。

结论

构建并验证了一个动态列线图和风险分层系统,以协助临床医生评估LADTC患者的预后风险并制定个性化治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fac5/12432967/c5bd13f803eb/gs-14-08-1497-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fac5/12432967/ff34d3df4451/gs-14-08-1497-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fac5/12432967/9b9eb732cae5/gs-14-08-1497-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fac5/12432967/c3f9bbd4dd19/gs-14-08-1497-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fac5/12432967/4e66d6518dab/gs-14-08-1497-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fac5/12432967/c5bd13f803eb/gs-14-08-1497-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fac5/12432967/ff34d3df4451/gs-14-08-1497-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fac5/12432967/9b9eb732cae5/gs-14-08-1497-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fac5/12432967/c3f9bbd4dd19/gs-14-08-1497-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fac5/12432967/4e66d6518dab/gs-14-08-1497-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fac5/12432967/c5bd13f803eb/gs-14-08-1497-f6.jpg

相似文献

1
A dynamic nomogram and risk stratification system for predicting cancer-specific survival in patients with locally advanced differentiated thyroid cancer: a population-based study.一种用于预测局部晚期分化型甲状腺癌患者癌症特异性生存的动态列线图和风险分层系统:一项基于人群的研究。
Gland Surg. 2025 Aug 31;14(8):1497-1509. doi: 10.21037/gs-2025-111. Epub 2025 Aug 26.
2
Development and validation of a nomogram for predicting overall and cancer-specific survival in elderly patients (≥ 65 years) with epithelial ovarian cancer.用于预测老年(≥65岁)上皮性卵巢癌患者总生存期和癌症特异性生存期的列线图的开发与验证。
Eur J Med Res. 2025 Sep 1;30(1):831. doi: 10.1186/s40001-025-03114-0.
3
The novel dynamic nomogram and risk classification system constructed for predicting post-surgical overall survival and mortality risk in primary chondrosarcoma: a population study based on SEER database.为预测原发性软骨肉瘤术后总生存率和死亡风险构建的新型动态列线图和风险分类系统:一项基于监测、流行病学和最终结果(SEER)数据库的人群研究。
J Cancer Res Clin Oncol. 2023 Nov;149(14):12765-12778. doi: 10.1007/s00432-023-05143-w. Epub 2023 Jul 15.
4
Two web-based dynamically interactive nomograms and risk stratification systems for predicting survival outcomes and guiding treatment in non-metastatic nasopharyngeal carcinoma.用于预测非转移性鼻咽癌生存结局并指导治疗的两个基于网络的动态交互式列线图和风险分层系统。
J Cancer Res Clin Oncol. 2023 Nov;149(17):15969-15987. doi: 10.1007/s00432-023-05363-0. Epub 2023 Sep 8.
5
Development and validation of nomograms for predicting survival of locally advanced rectosigmoid junction cancer patients: a SEER database analysis.预测局部晚期直肠乙状结肠交界处癌患者生存的列线图的开发与验证:一项监测、流行病学和最终结果(SEER)数据库分析
Transl Cancer Res. 2025 May 30;14(5):2808-2821. doi: 10.21037/tcr-24-1810. Epub 2025 May 27.
6
Establishment of a prognostic nomogram for intrahepatic cholangiocarcinoma patients receiving chemotherapy: a SEER-based study.建立接受化疗的肝内胆管癌患者的预后列线图:一项基于监测、流行病学和最终结果(SEER)数据库的研究
J Gastrointest Oncol. 2025 Aug 30;16(4):1562-1572. doi: 10.21037/jgo-2025-143. Epub 2025 Aug 25.
7
Dynamic nomogram for predicting the overall survival and cancer-specific survival of patients with gastrointestinal neuroendocrine tumor: a SEER-based retrospective cohort study and external validation.预测胃肠道神经内分泌肿瘤患者总生存期和癌症特异性生存期的动态列线图:一项基于监测、流行病学和最终结果(SEER)数据库的回顾性队列研究及外部验证
Front Oncol. 2025 Jun 4;15:1594591. doi: 10.3389/fonc.2025.1594591. eCollection 2025.
8
Utilizing tumor deposit count as a stratification criterion in revising TNM staging system for patients with colorectal cancer: a nomogram review study.利用肿瘤沉积计数作为修订结直肠癌患者TNM分期系统的分层标准:一项列线图回顾性研究
Front Oncol. 2025 Aug 25;15:1605030. doi: 10.3389/fonc.2025.1605030. eCollection 2025.
9
Construction and evaluation of a mortality prediction model for patients with acute kidney injury undergoing continuous renal replacement therapy based on machine learning algorithms.基于机器学习算法的行连续性肾脏替代治疗的急性肾损伤患者死亡率预测模型的构建与评估。
Ann Med. 2024 Dec;56(1):2388709. doi: 10.1080/07853890.2024.2388709. Epub 2024 Aug 19.
10
Development and validation of a nomogram for predicting overall survival of resected N2 non-small cell lung cancer patients undergoing neoadjuvant radiotherapy.开发并验证了一个列线图模型,用于预测接受新辅助放疗的可切除 N2 期非小细胞肺癌患者的总生存情况。
J Cancer Res Clin Oncol. 2023 Oct;149(13):11779-11790. doi: 10.1007/s00432-023-05073-7. Epub 2023 Jul 5.

本文引用的文献

1
Development and validation of a prognostic nomogram for predicting mortality risk in adult rheumatoid arthritis: an analysis of NHANES 1999-2018 data.用于预测成人类风湿性关节炎死亡风险的预后列线图的开发与验证:基于1999 - 2018年美国国家健康与营养检查调查(NHANES)数据的分析
Front Immunol. 2025 Apr 17;16:1592958. doi: 10.3389/fimmu.2025.1592958. eCollection 2025.
2
Identification of Risk Factors for Cause-specific Mortality in Advanced Papillary Thyroid Cancer and Construction of a Competing Risk Model: A SEER-Based Study.晚期甲状腺乳头状癌特定病因死亡率的危险因素识别及竞争风险模型的构建:一项基于监测、流行病学和最终结果(SEER)数据库的研究
Cancer Control. 2025 Jan-Dec;32:10732748251336412. doi: 10.1177/10732748251336412. Epub 2025 Apr 23.
3
Interpretable machine learning for thyroid cancer recurrence predicton: Leveraging XGBoost and SHAP analysis.
用于甲状腺癌复发预测的可解释机器学习:利用XGBoost和SHAP分析
Eur J Radiol. 2025 May;186:112049. doi: 10.1016/j.ejrad.2025.112049. Epub 2025 Mar 14.
4
A prognostic nomogram for distant metastasis in thyroid cancer patients without lymph node metastasis.用于无淋巴结转移的甲状腺癌患者远处转移的预后列线图。
Front Endocrinol (Lausanne). 2025 Feb 17;16:1523785. doi: 10.3389/fendo.2025.1523785. eCollection 2025.
5
A nomogram for predicting cancer-specific survival in patients with locally advanced unresectable esophageal cancer: development and validation study.预测局部晚期不可切除食管癌患者癌症特异性生存的列线图:开发与验证研究
Front Immunol. 2025 Feb 14;16:1524439. doi: 10.3389/fimmu.2025.1524439. eCollection 2025.
6
A nomogram for individualized prediction for cervical lymph node metastasis of papillary thyroid carcinoma.一种用于个体化预测甲状腺乳头状癌颈部淋巴结转移的列线图。
Gland Surg. 2024 Nov 30;13(11):1965-1976. doi: 10.21037/gs-24-277. Epub 2024 Nov 26.
7
Analysis of the ideal cutoff age as a predictor of differentiated thyroid cancer using the Surveillance, Epidemiology, and End Results database.利用监测、流行病学和最终结果数据库分析理想的临界年龄作为分化型甲状腺癌预测指标的情况。
Transl Cancer Res. 2024 Aug 31;13(8):4278-4289. doi: 10.21037/tcr-24-247. Epub 2024 Aug 6.
8
Global burden of thyroid cancer from 1990 to 2021: a systematic analysis from the Global Burden of Disease Study 2021.全球 1990 年至 2021 年甲状腺癌负担:2021 年全球疾病负担研究的系统分析。
J Hematol Oncol. 2024 Aug 27;17(1):74. doi: 10.1186/s13045-024-01593-y.
9
Neoadjuvant Treatment of Locally Advanced Thyroid Cancer: A Preliminary Latin American Experience.局部晚期甲状腺癌的新辅助治疗:初步的拉丁美洲经验。
Thyroid. 2024 Jul;34(7):949-952. doi: 10.1089/thy.2024.0090. Epub 2024 Jun 3.
10
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.